Milestone Pharmaceuticals shares rise 1.38% intraday after Orexo's seminar on patent strategies in Sweden.

Milestone Pharmaceuticals Inc. rose 1.38% in intraday trading. The company's stock price increase may be attributed to the recent news event where Orexo (publ.), in collaboration with its advisory international law firms Potter Clarkson LLP and Steptoe LLP, will host a seminar on building robust patent strategies that will protect pharmaceutical IP even in the face of hostile generic opposition. This event, targeting innovators, pharma companies, biotech firms, and investors, will provide real-life insights into how a company ultimately looking to sell their product in the US.